BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9177463)

  • 21. p53 antibodies in patients with various types of cancer: assay, identification, and characterization.
    Lubin R; Schlichtholz B; Teillaud JL; Garay E; Bussel A; Wild CP
    Clin Cancer Res; 1995 Dec; 1(12):1463-9. PubMed ID: 9815945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-p53 antibodies in serum of smokers and head and neck cancer patients.
    Wollenberg B; Jan NV; Pitzke P; Reiter W; Stieber P
    Anticancer Res; 1997; 17(1A):413-8. PubMed ID: 9066686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward Liquid Biopsy: Determination of the Humoral Immune Response in Cancer Patients Using HaloTag Fusion Protein-Modified Electrochemical Bioplatforms.
    Garranzo-Asensio M; Guzman-Aranguez A; Povés C; Fernández-Aceñero MJ; Torrente-Rodríguez RM; Ruiz-Valdepeñas Montiel V; Domínguez G; Frutos LS; Rodríguez N; Villalba M; Pingarrón JM; Campuzano S; Barderas R
    Anal Chem; 2016 Dec; 88(24):12339-12345. PubMed ID: 28193070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen.
    Dong X; Hamilton KJ; Satoh M; Wang J; Reeves WH
    J Exp Med; 1994 Apr; 179(4):1243-52. PubMed ID: 8145041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of serum anti-p53 antibodies from patients with ovarian cancer in China: correlation to clinical parameters.
    Qiu T; Yang Q; Li XR; Yang H; Qiu LL; Wang L
    Cancer Invest; 2007; 25(7):563-8. PubMed ID: 17952741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to p53 in sera of patients with autoimmune thyroid disease.
    Fenton CL; Patel A; Tuttle RM; Francis GL
    Ann Clin Lab Sci; 2000 Apr; 30(2):179-83. PubMed ID: 10807162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma.
    Gadducci A; Ferdeghini M; Buttitta F; Cosio S; Fanucchi A; Annicchiarico C; Genazzani AR
    Anticancer Res; 1998; 18(5B):3763-5. PubMed ID: 9854491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
    Tsai-Turton M; Santillan A; Lu D; Bristow RE; Chan KC; Shih IeM; Roden RB
    Gynecol Oncol; 2009 Jul; 114(1):12-7. PubMed ID: 19398128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the p53 gene and presence of serum autoantibodies in ovarian cancer: correlation with differentiation.
    Green JA; Robertson LJ; Campbell IR; Jenkins J
    Cancer Detect Prev; 1995; 19(2):151-5. PubMed ID: 7750102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies.
    Herkel J; Mimran A; Erez N; Kam N; Lohse AW; Märker-Hermann E; Rotter V; Cohen IR
    J Autoimmun; 2001 Aug; 17(1):63-9. PubMed ID: 11488638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma.
    Friedrich RE; Bartel-Friedrich S; Plambeck K; Bahlo M; Klapdor R
    Anticancer Res; 1997; 17(4B):3183-4. PubMed ID: 9329632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N- or C-terminus of p53.
    Saleh J; Kreissler-Haag D; Montenarh M
    Int J Oncol; 2004 Oct; 25(4):1149-55. PubMed ID: 15375567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure.
    Fénichel P; Sosset C; Barbarino-Monnier P; Gobert B; Hiéronimus S; Béné MC; Harter M
    Hum Reprod; 1997 Dec; 12(12):2623-8. PubMed ID: 9455825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
    Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
    Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibody formation to cellular p53 protein in patients with squamous cell carcinomas of the upper respiratory and digestive system].
    Maass JD; Gottschlich S; Lippert BM; Niemann AM; Görögh T; Werner JA
    Laryngorhinootologie; 1996 Jan; 75(1):53-6. PubMed ID: 8851121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma.
    Olejek A; Damasiewicz-Bodzek A; Bodzek P; Wielkoszyński T; Zamłyński J; Stołtny P; Skutil M
    Int J Gynecol Cancer; 2009 Dec; 19(9):1516-20. PubMed ID: 19955928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
    Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum anti-p53 autoantibodies in patients with type 1 diabetes.
    Di Cesare E; Previti M; Lombardo F; Di Benedetto A; Mazzù N; Romano G; De Luca F; Lasco A; Cucinotta D
    Ann Clin Lab Sci; 2001 Jul; 31(3):253-8. PubMed ID: 11508828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
    Lenner P; Wiklund F; Emdin SO; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
    Br J Cancer; 1999 Feb; 79(5-6):927-32. PubMed ID: 10070892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer.
    Mitsudomi T; Suzuki S; Yatabe Y; Nishio M; Kuwabara M; Gotoh K; Hatooka S; Shinoda M; Suyama M; Ogawa M; Takahashi T; Ariyoshi Y; Takahashi T
    J Natl Cancer Inst; 1998 Oct; 90(20):1563-8. PubMed ID: 9790550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.